Biotech

All Articles

Cognition's period 2 beam data stain Alzheimer's prospect

.Cognition Therapies' stage 2 SHINE test has actually taken several of the radiance off the Alzheime...

BMS centers bispecific months after submitting to run period 3 trial

.Bristol Myers Squibb has actually had a whiplash change of heart on its own BCMA bispecific T-cell ...

Charles Baum takes over Terremoto as chief executive officer

.Charles Baum, M.D., Ph.D., that managed Mirati Rehabs' $ 5.8 billion sale to Bristol Myers Squibb i...

Asarina to close after efforts to companion Tourette's medication fail

.After connecting to more than 200 providers to companion a Tourette syndrome therapy that presented...

Novartis pens $150M in advance bispecifics manage Dren Bio

.Novartis has possessed some misfortune along with bispecific antitoxins in the past, however determ...

AstraZeneca vegetations an EGFR tree along with Pinetree deal worth $45M

.Pinetree Rehabs will aid AstraZeneca vegetation some trees in its own pipeline along with a brand-n...

GRO rounds up $60M set B to take gout treatment into facility

.GRO Biosciences has ended the week along with an additional $60.3 thousand in the banking company, ...

Chutes &amp Ladders-- Gilead's Merdad Parsey goes, Cassava loses CEO

.Accept to this week's Chutes &amp Ladders, our roundup of substantial leadership hirings, firings a...